AbbVie : ABBV

All AbbVie Articles

587 Articles

David Moadel | Apr 7, 2026 at 9:58 AM EDT

AbbVie Gets JPMorgan Buying Opportunity Call With $260 Price Target Amid Competitive Concerns

AbbVie (NYSE:ABBV | ABBV Price Prediction) stock has pulled back 12% over the past month, sliding to around $204. JPMorgan…

Vandita Jadeja | Apr 6, 2026 at 12:15 PM EDT

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

Pharmaceutical companies AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, revealing two…

Lee Jackson | Apr 2, 2026 at 8:10 AM EDT

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

With inflation back in the economic picture, simply getting a dependable income stream may not be the best strategy for…

John Seetoo | Mar 27, 2026 at 11:49 AM EDT

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

Retirees and income-focused investors have long used Vanguard Value ETF (NYSEARCA:VTV) as a core portfolio anchor, drawn to its dividend…

Michael Williams | Mar 26, 2026 at 2:32 PM EDT

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

Healthcare spending doesn’t stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT),…

John Seetoo | Mar 25, 2026 at 1:30 PM EDT

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

A 1.5% yield sounds unimpressive until you realize the dividend check doubles roughly every seven years. That is the premise…

Chris MacDonald | Mar 20, 2026 at 10:02 AM EDT

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

Growth investing has had a choppy start to 2026. The major growth benchmarks are down in the low single digits…

Austin Smith | Mar 20, 2026 at 8:02 AM EDT

JP Morgan’s Dividend Leaders ETF Sounds Good, But The Yield Underwhelms

JPMorgan Dividend Leaders ETF (NYSEARCA:JDIV) launched in September 2024 with an appealing premise: a curated portfolio of global dividend leaders.…

Austin Smith | Mar 13, 2026 at 9:12 AM EDT

If You Have $500,000 Saved at 60, Here’s The Sort of Monthly Income You Can Count On

At 60 with $500,000 saved, you are closer to a workable retirement income than most people realize. The math is…

Austin Smith | Mar 11, 2026 at 12:37 PM EDT

Josh Brown: Biotech growth stocks immune to disruption risk

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap biotech:…

Austin Smith | Mar 8, 2026 at 9:54 AM EDT

Retirees Take Note: DGRO Yields 2.4%, Has Raised Its Dividend Every Single Year for Over a Decade

DGRO has raised its annual dividend every single year since inception, through a pandemic, a rate-hiking cycle, and multiple bouts…

Austin Smith | Mar 8, 2026 at 9:00 AM EDT

This 5-Star ETF Pays Monthly Dividends and Has Never Missed in 19 Years

For retirees piecing together income from multiple sources, WisdomTree U.S. High Dividend Fund (NYSEARCA:DHS) has become a quiet staple. With…

Lee Jackson | Feb 25, 2026 at 7:57 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

Pre-Market Stock Futures: Futures are trading higher this morning, but what a difference a day makes after a “Meltdown Monday.” …

Eric Bleeker | Feb 23, 2026 at 8:02 AM EST

Crown Castle and AT&T Tumble While Coca-Cola Rises as Dividened Stocks Take a Breather

It’s been a fantastic 2026 for most dividend stocks so far this year, but most dividend-payers took a break last…

Joel South | Feb 12, 2026 at 12:37 PM EST

This Is Graco’s Dividend Score After Paying Investors

Graco just paid investors $0.295 per share on February 4, 2026, marking the company’s 27th consecutive year of quarterly dividend…

1 2 3 4 5 … 40

AbbVie : ABBV

All AbbVie Articles

AbbVie Gets JPMorgan Buying Opportunity Call With $260 Price Target Amid Competitive Concerns

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

JP Morgan’s Dividend Leaders ETF Sounds Good, But The Yield Underwhelms

If You Have $500,000 Saved at 60, Here’s The Sort of Monthly Income You Can Count On

Josh Brown: Biotech growth stocks immune to disruption risk

Retirees Take Note: DGRO Yields 2.4%, Has Raised Its Dividend Every Single Year for Over a Decade

This 5-Star ETF Pays Monthly Dividends and Has Never Missed in 19 Years

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

Crown Castle and AT&T Tumble While Coca-Cola Rises as Dividened Stocks Take a Breather

This Is Graco’s Dividend Score After Paying Investors

The $2,400 Widow’s Benefit Myth: Why Claiming Early Doesn’t Cap What a Widow Receives

1 Plain-As-Day Dividend King to Buy on the Dip That Has Hiked Its Payout for 70 Consecutive Years

Forget SCHD: This Monthly Dividend Grower Out-Returned It by 38% Over the Last Decade

You Have $1 Million. Should You Retire In Sarasota Or Naples?

The $2,400 Widow's Benefit Myth: Why Claiming Early Doesn't Cap What a Widow Receives

You Have $1 Million. Should You Retire In Sarasota Or Naples?

The $2,400 Widow’s Benefit Myth: Why Claiming Early Doesn’t Cap What a Widow Receives

AbbVie : ABBV

All AbbVie Articles

AbbVie Gets JPMorgan Buying Opportunity Call With $260 Price Target Amid Competitive Concerns

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

JP Morgan’s Dividend Leaders ETF Sounds Good, But The Yield Underwhelms

If You Have $500,000 Saved at 60, Here’s The Sort of Monthly Income You Can Count On

Josh Brown: Biotech growth stocks immune to disruption risk

Retirees Take Note: DGRO Yields 2.4%, Has Raised Its Dividend Every Single Year for Over a Decade

This 5-Star ETF Pays Monthly Dividends and Has Never Missed in 19 Years

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

Crown Castle and AT&T Tumble While Coca-Cola Rises as Dividened Stocks Take a Breather

This Is Graco’s Dividend Score After Paying Investors

The $2,400 Widow’s Benefit Myth: Why Claiming Early Doesn’t Cap What a Widow Receives

1 Plain-As-Day Dividend King to Buy on the Dip That Has Hiked Its Payout for 70 Consecutive Years

Forget SCHD: This Monthly Dividend Grower Out-Returned It by 38% Over the Last Decade

Featured Reads

You Have $1 Million. Should You Retire In Sarasota Or Naples?

The $2,400 Widow's Benefit Myth: Why Claiming Early Doesn't Cap What a Widow Receives